Abstract
Background:
Lingual necrosis is a rare complication of giant cell arteritis (GCA).
Methods:
A 77-year-old woman presented for treatment of a painful and discolored tongue, odynophagia, and dehydration refractory to antimicrobials over 2 weeks. An extensive, well-demarcated necrotic area was visualized on the anterior tongue upon admission. Leukocytosis, thrombocytosis, and elevated erythrocyte sedimentation rate were present. Computed tomography angiogram of the head and neck revealed an undulated-beaded appearance of the distal internal carotid arteries and vertebral arteries bilaterally.
Results:
High-dose intravenous steroids were initiated for suspected vasculitis. Temporal artery biopsy confirmed the diagnosis of GCA. The patient’s condition improved and the anterior tongue was well healed at 1 month follow-up.
Conclusions:
An atypical presentation of GCA (eg, isolated lingual necrosis) risks a delay in diagnosis and increased morbidity. Any patient above the age of 50 years presenting with tongue necrosis, in the absence of known cause, should undergo expedited workup for GCA.
Introduction
Giant cell arteritis (GCA) is a large-vessel vasculitis often presenting with headache, jaw claudication, and temporal scalp tenderness. If unrecognized and left untreated, the disease process can progress to potentially irreversible cranial ischemic complications. These may include permanent loss of vision (most commonly due to anterior ischemic optic neuropathy), 1 extraocular motility disorders resulting in diplopia, 2 and uncommonly, cerebral infarct in either the vertebrobasilar or internal carotid artery distributions. 3
Lingual necrosis is a known but rare initial manifestation of GCA, and due to the rich vascular supply of the tongue, bilateral lingual necrosis is even more unusual.4,5 This uncommon manifestation of GCA should not be overlooked due to the potential complications related to untreated disease.
Here, we present a rare case of a patient ultimately diagnosed with GCA whose only initial presenting symptom was lingual ischemia and necrosis.
Case Report
A 77-year-old woman presented to the emergency room for treatment of oral tongue pain, odynophagia, and dehydration. She reported a 2-week history of progressively worsening tongue pain with ulceration and odynophagia. The patient stated that her tongue was blue in color before the onset of ulceration (Figure 1). She denied having any associated fevers, chills, malaise, scalp or jaw tenderness, headaches, or vision changes. Initially, the patient was treated by her primary care physician for a presumed infection and was prescribed Bactrim, then Augmentin, with progression of her symptoms. Her odynophagia led to severe dehydration that required a short hospitalization at an outside facility 1 week prior to presentation. The patient was seen by an infectious disease physician and underwent continued antimicrobial treatment with addition of acyclovir and fluconazole as an outpatient.

Ischemic changes to the anterior tongue.
Upon evaluation by the otolaryngology service, the patient was noted to have dry mucous membranes, and there was an extensive, but well-demarcated, area of necrosis involving the anterior one-third to half of the oral tongue (Figure 2). The tongue was tender to palpation.

Lingual necrosis present upon initial presentation.
Laboratory studies revealed that the patient had a leukocytosis of 22 K/µL, thrombocytosis of 716 K/µL, and erythrocyte sedimentation rate (ESR) that was elevated to 65 mm/h. Computed tomography (CT) angiogram of the head and neck revealed an undulated-beaded appearance of the distal internal carotid arteries and vertebral arteries bilaterally. Biopsy of the tongue revealed marked acute inflammation and granulation tissue with focal loss of the squamous mucosa above the basal layer. No fungal elements were identified with staining, and no viruses (cytomegalovirus, herpes simplex virus, or varicella zoster virus) were identified with immunohistochemistry markers.
The rheumatology service was consulted due to concern for vasculitis and the patient was started on high-dose intravenous steroids. A transthoracic echocardiogram was not performed due to low suspicion for an emboligen cardiopathy in the absence of an arrhythmia or artificial valve. The patient was taken to the operating room for a left superficial temporal artery biopsy. Histology revealed reduction of the vessel lumen caliber due to intimal hyperplasia, fragmentation of the internal elastic lamina, and transmural mononuclear cell infiltrate, confirming the diagnosis of GCA. With long-term high-dose steroids, the patient’s pain resolved and the tongue necrosis stopped progressing. She eventually recovered and the anterior edge of the tongue was well-healed 6 months after presentation (Figure 3).

Six months after initial presentation and long-term steroid treatment.
Discussion
Giant cell arteritis, also historically known as temporal arteritis, cranial arteritis, or Horton disease, is a large-vessel vasculitis. This disease typically affects older adults above the age of 50 years, affects women twice as often as men, and has an overall disease prevalence of 1:500. 6 Associated constitutional symptoms may include fever, malaise, arthralgia, weight loss, and night sweats. More specific symptoms include temporal headaches, transient monocular visual loss or amaurosis fugax, tongue or jaw claudication, or scalp tenderness with or without necrosis. Lingual necrosis is a rare manifestation of GCA, with only 29 previously reported cases in the literature.7–10 The tongue receives its main vascular supply from branches of the external carotid artery, which is preferentially affected in GCA. Due to rich vascular feed from branches of the lingual, facial, pharyngeal and palatine arteries, unilateral presentation of lingual necrosis is more common than bilateral presentation.
During the medical workup for GCA, an elevated ESR is often seen, but on rare occasions may still be normal. 11 Serum C-reactive protein (CRP) is another acute phase marker that may be correlated to disease activity. The traditional gold standard for diagnosis of GCA is temporal artery biopsy; the classic histopathologic finding of mononuclear cell infiltration of the artery wall is diagnostic. 12 The American College of Rheumatology recommends that 3 out of the 5 following criteria are necessary for diagnosis: aged above 50 years, new onset of localized headache, tenderness or decreased pulse in the temporal artery, ESR >50 mm in the first hour, and classic findings on temporal artery biopsy. 6 Meller et al 13 found that fluorodeoxyglucose (FDG) uptake greater than or equal to that of liver uptake could also be used as criterion to detect vascular inflammation and was more reliable than magnetic resonance imaging (MRI) in a subset of patients. While the threshold of significance has not yet been determined for this application of FDG-positron emission tomography (PET), this imaging modality may offer a non-invasive way to diagnose GCA in the future. 14
Treatment of GCA involves induction therapy, typically starting the patient on high-dose glucocorticoids as soon as GCA is clinically suspected. This is followed by maintenance therapy with lower dose steroids and management of flares should they occur. 15 Notably, necrotic tongue ulcerations may occur in delayed fashion even after 1 week or more of appropriate glucocorticoid treatment. 7 Mahr et al 16 in 2007 published a meta-analysis from pooled data from 3 randomized control trials and found that adjunctive treatment using methotrexate may lower the risk of relapse and reduce the overall dose of steroids administered to the patients. Methotrexate has also been chosen as early adjuvant therapy for GCA in part due to the presence of lingual necrosis, which portends worse prognosis. 8 The recent GiACTA trial found that the addition of tocilizumab, an interleukin (IL)-6 inhibitor, to a prednisone taper was superior to both short- and long-term prednisone alone for the primary outcome of sustained remission at 52 weeks. 17
Table 1 provides a summary of case reports in which lingual ischemia and necrosis was the primary initial manifestation of GCA, occurring either in the absence of, or prior to, classic symptoms such as headache, visual disturbances, or jaw claudication. Herein, we focus only on cases of isolated lingual necrosis that resulted in delay of diagnosis, rather than attempting a review of all cases of lingual necrosis complicating GCA such as the one performed by Sobrinho et al. 8 Such an atypical presentation risks a delay of appropriate care, as evidenced by the fact that antimicrobial therapy was also an initial treatment of choice in several other instances.4,5,18 The differential for tongue necrosis includes other ischemic causes such as embolism or hemorrhage, septic or cardiogenic shock, malignant tumors, infection or abscess, intake of ergotamine drugs, previous history of radiation to the head and neck, or other vasculitides such as granulomatosis with polyangiitis or polyarteritis nodosa.18–20 However, it would behoove the clinician to be aware that GCA is likely the most common cause of lingual necrosis when it does present. 21
Case reports describing lingual necrosis as the primary initial clinical manifestation of giant cell arteritis.
Abbreviations: ACR, American College of Rheumatology; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK-MB, creatine kinase-muscle/brain; CRP, C-reactive protein; CTA, computed tomography angiogram; ESR, erythrocyte sedimentation rate; FDG-PET, fluorodeoxyglucose-positron emission tomography; GCA, giant cell arteritis; MRA, magnetic resonance angiogram.
Although a diagnosis of GCA was not immediately apparent in any of the 7 previous cases, the majority of patients satisfied at least 3 diagnostic criteria as set by the ACR (Table 1). However, empiric steroids should never be delayed to await confirmation if there is high clinical suspicion. 4 Temporal artery biopsy is not a perfectly sensitive method due to the segmental nature of lesions in GCA, and in one case, the authors considered the diagnosis definitive only after observing excellent therapeutic response to prednisone and exclusion of differential diagnoses. 5 In any patient presenting with lingual necrosis, it is important to undergo repeated, specific questioning regarding the possible coexistence of more vague classic manifestations of GCA that may otherwise go unreported. 4 Brodmann et al 22 recommends ESR and duplex sonography of the temporal arteries in the setting of any unexplained tongue necrosis, with subsequent biopsy in the event of uncertainty. In the CT angiography of our patient, the undulated-beaded appearance of the distal internal carotid and vertebral arteries bilaterally was more consistent with skip lesions occurring secondary to a vasculitic process than diffuse atherosclerosis. While CTA is less sensitive than MRI for diagnosing cerebral vasculitis, 23 the presence of intracranial vascular lesions in a segmental pattern provided enough grounds for initiation of glucocorticoids and scheduling a superficial temporal artery biopsy rather than evaluation for cardioembolic or infectious origin.
Conclusions
Giant cell arteritis may present with vague constitutional symptoms including fever, malaise, arthralgia, weight loss, and night sweats. High clinical suspicion is necessary to diagnose and treat the disease before irreversible ischemia and blindness occur. Bilateral lingual ischemia and necrosis is a rare manifestation and potentially reversible complication of this disease. It is imperative that otolaryngologists be able to recognize cases of GCA in which lingual necrosis is the only presenting symptom to mitigate morbidity and mortality resulting from delayed diagnosis. The authors recommend that any patient above the age of 50 years presenting with tongue necrosis, in the absence of known cause, should undergo expedited workup for GCA.
Footnotes
Acknowledgements
This paper was presented as a Poster Submission to the American Academy of Otolaryngology—Head and Neck Surgery Annual Meeting in San Diego, CA, September 18-21, 2016.
Funding:
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Declaration of conflicting interests:
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Author Contributions
I.C. and N.E.L. conceived the the project. L.C.D. collected clinic information and data, and wrote the manuscript with the support of I.C. and N.E.L. L.C.D., I.C., and N.E.L. contributed to the final version of the manuscript.
Informed Consent
The patient provided informed consent for the authors to publish images and discuss the case presentation.
